105 related articles for article (PubMed ID: 12395933)
1. ELISA measurement of interferons.
Garrison TL; Hung F; Izotova L; Schwartz B; Lavoie T; Lee-Own FV
Biotechniques; 2002 Oct; Suppl():98-100. PubMed ID: 12395933
[No Abstract] [Full Text] [Related]
2. Convenient biological assay for polyethylene glycol-interferons in patients with hepatitis C.
Boulestin A; Kamar N; Legrand-Abravanel F; Sandres-Saune K; Alric L; Vinel JP; Rostaing L; Izopet J
Antimicrob Agents Chemother; 2004 Sep; 48(9):3610-2. PubMed ID: 15328140
[TBL] [Abstract][Full Text] [Related]
3. [Stimulation of interferon formation in tissue culture by means of 8-mercaptoadenine].
Braude AI; Shcherbakova EG; Smertenko II; Furer NM; Rastunova GA
Antibiotiki; 1969 Oct; 14(10):915-8. PubMed ID: 4311306
[No Abstract] [Full Text] [Related]
4. Assays for antiviral activity.
Meager A
Methods Mol Biol; 2004; 249():121-34. PubMed ID: 14573896
[No Abstract] [Full Text] [Related]
5. Antiviral activity of oligomerization-deficient Stat1.
Vinkemeier U; Meyer T
Genome Inform; 2005; 16(1):44-8. PubMed ID: 16362905
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the biological activities and physicochemical characteristics of recombinant bovine interferon-α₁₄.
Shao J; Cao C; Bao J; Gao M; Wang J
Mol Immunol; 2015 Mar; 64(1):163-9. PubMed ID: 25480392
[TBL] [Abstract][Full Text] [Related]
7. [How to make an ally of an "inactive" product: the example of interferon].
Lavelle F
Bull Cancer; 2000 Sep; 87(9):621-2. PubMed ID: 11184449
[No Abstract] [Full Text] [Related]
8. Antiviral activity of some copper complexes of as-triazines.
Popescu A; Jucu V; Tomas E; Zuiwertz A; Cristescu C; Tomas S
Rev Roum Virol; 1992; 43(1-2):125-6. PubMed ID: 1337700
[No Abstract] [Full Text] [Related]
9. New simple dye-uptake assay for interferon.
Imanishi J; Hoshino S; Hoshino A; Oku T; Kita M; Kishida T
Biken J; 1981 Sep; 24(3):103-8. PubMed ID: 6175308
[TBL] [Abstract][Full Text] [Related]
10. Pegylation of IFN-alpha and antiviral activity.
Boulestin A; Kamar N; Sandres-Sauné K; Alric L; Vinel JP; Rostaing L; Izopet J
J Interferon Cytokine Res; 2006 Dec; 26(12):849-53. PubMed ID: 17238827
[TBL] [Abstract][Full Text] [Related]
11. Prolonging the half-life of human interferon-alpha 2 in circulation: Design, preparation, and analysis of (2-sulfo-9-fluorenylmethoxycarbonyl)7- interferon-alpha 2.
Shechter Y; Preciado-Patt L; Schreiber G; Fridkin M
Proc Natl Acad Sci U S A; 2001 Jan; 98(3):1212-7. PubMed ID: 11158619
[TBL] [Abstract][Full Text] [Related]
12. [More rapid method of microtitration of murine interferons by retarding the cytopathogenic effect of vesicular stomatitis virus].
Pavlushina SV; Orlova TG
Vopr Virusol; 1981; (2):242-3. PubMed ID: 6168118
[No Abstract] [Full Text] [Related]
13. Greater sensitivity of caprine synovial membrane cells to human interferon-alpha than human or bovine cells.
Yilma T; Breeze RG; Leib SR
Am J Vet Res; 1984 Oct; 45(10):2094-5. PubMed ID: 6093643
[TBL] [Abstract][Full Text] [Related]
14. Mode of selection and experimental evolution of antiviral drugs resistance in vesicular stomatitis virus.
Cuevas JM; Sanjuán R; Moya A; Elena SF
Infect Genet Evol; 2005 Jan; 5(1):55-65. PubMed ID: 15567139
[TBL] [Abstract][Full Text] [Related]
15. Studies on interferon induction and antiviral activity by certain arboviruses.
Takehara M
Kobe J Med Sci; 1975 Mar; 21(1):23-32. PubMed ID: 170452
[No Abstract] [Full Text] [Related]
16. [On the joint effect of interferon and histone on the cytopathic effect of vesicular stomatitis virus].
Balandin IG; Diuĭsalieva RG; Kol'tsov VD; Lushnikov AA
Vopr Virusol; 1968; 13(5):630. PubMed ID: 4303598
[No Abstract] [Full Text] [Related]
17. Antiviral activity of interferon in human embryo fibroblasts of variable cultivation age.
Povolotskii YL; Krivokhatskaya LD; Spivak NY
J Hyg Epidemiol Microbiol Immunol; 1981; 25(2):182-7. PubMed ID: 6166669
[No Abstract] [Full Text] [Related]
18. Analysis of the antiviral activities of natural IFN-alpha preparations and their subtype compositions.
Yanai Y; Sanou O; Kayano T; Ariyasu H; Yamamoto K; Yamauchi H; Ikegami H; Kurimoto M
J Interferon Cytokine Res; 2001 Oct; 21(10):835-41. PubMed ID: 11710996
[TBL] [Abstract][Full Text] [Related]
19. [Obtaining and characteristics of domestic preparation interferon alpha-2b with prolonged effect].
Pokholenko IaA; Porubleva LV; Dubeĭ IIa; Rebriev AV; Sutugina LP; Gromovoĭ TIu; Pokrovskiĭ VA; Obolenskaia MIu; Chernykh SI
Ukr Biokhim Zh (1999); 2008; 80(6):92-100. PubMed ID: 19351063
[TBL] [Abstract][Full Text] [Related]
20. Comparison of an antiviral activity of recombinant consensus interferon with recombinant interferon-alpha-2b.
Koyama AH; Arakawa T; Adachi A
Microbes Infect; 1999 Nov; 1(13):1073-7. PubMed ID: 10572309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
